The Indices That Tripped Up JPMorgan
An in-depth technical look at the indices at the center of the JPMorgan trading loss. The IG9 alone has $800 billion of tranches outstanding and would be extremely difficult to value.
Starting with “on the run” indices:
Looking at IG (investment grade), HY (high yield), MAIN (Europe), and FINS (financial), you see a very typical trend. The net is increasing in the “on the run” series and decreasing in the older or “off the run” series. That is typical as investors, speculators, hedgers, special purpose investment vehicles, funds, etc., want to remain in the more liquid "on the run" series.
The overall reduction in HY and XOVER (a credit index comprising a mix of high yield and higher yielding investment grade names) is interesting. Also, even in financials, the riskier sub index experienced a net decrease. I’m not sure what it means. Complacency? Increased volatility forcing smaller position sizes? JPMorgan (JPM) cutting HY short and shorting IG18, against IG9?
Looking at this, other than not being able to explain the net reductions in the riskiest indices, the rest of the positioning looks like traditional role activity.
This data is a bit more interesting, especially in light of all the “Whale” questions.
It looks like positions in European indices got reduced pretty dramatically. On Series 9 you saw large reductions in the net exposure on both the tranche and the index side. This is indicative of correlation desks reducing positions as they would have both sides of the trade. Since the net is relatively close, it was either some senior (low leverage) tranches being unwound, or some real risk reduction in outright tranches.
Across some old series, the reduction in net exposure is across the board (and in Series 15). The total for those four tranches is a meaningful reduction. There was less of a move in the untranched indices, which seems to mean that these were outright tranches, or someone was hedging more with single names or more liquid indices. A bit weird, but could have been some serious risk reduction.
IG9 tranche net actually increased in the period, though outright index dropped off. Is that a sign that it was hard to get out of tranches? IG9 with that special place in everyone’s heart, does seem strange.
IG8 and IG7 both had serious amounts of notional reductions in the tranched and untranched. The ratio of tranche to index in them is very different with IG7 looking like it must have been some very risky tranches (big ratio).
IG15 and IG6 both had decent reductions. Not sure what if anything it means.
HY10, one that JPMorgan was allegedly short, had a reduction as well. Assuming this was the “five-year” tranche, it matures in June 2013.
There has been so much talk about IG9 and the basis, and how much JPMorgan must have lost since the announcement based on eyeballing IG9 or the basis, but the story is far more complex than that.
HY10 is currently at 102. That is lower than it was before the JPMorgan announcement when it was trading at 102.5. At the end of April, when it was pretty clear that JPMorgan was aware of the problems in the chief investment office, this was at 102.75, so it may have gained back a lot of the losses. It is pretty unclear what the exact date the $2 billion was. Probably marked closer to the conference call than month end, but not sure exactly. This index was pretty stable the entire month, so while IG was getting wider one of its shorts wasn’t moving (and was bleeding carry daily). That is consistent with JPMorgan losing money according to guesses on position, but it's down well since then.
I am getting some additional price history on tranches. That is a painful exercise, but to put it in perspective, they are volatile and pricing is completely dependent on where you are. The 3-6% tranche of IG9 10-year was recently 36% up front plus 500 running. The “super senior” was 54 bps (basis points) running. Assuming the Whale was at lower end, we have seen some serious volatility in that. While IG9 10-year was tightening the entire first quarter, it is possible the tranche was underperforming. JPMorgan may have made some money, but not much. Then when the index started widening, the tranches moved in step. So that by the time the index itself was tighter on the year, the naked tranches could have been wider on the year. It is that breakdown of correlation that could have occurred that would have explained the losses. So more important than how IG9 is moving, is how the tranches in IG9 are moving and if the “delta” equivalent remains the same.
Guessing what they have is almost impossible, but any guess that looks at IG9 and assumes the worst is probably more wrong than right.
In any case, all these products need to be moved to an exchange. Look at the huge differential between the gross notional and the net notional exposure; this should go down. Yes, banks would have to unwind offsetting trades, but who cares? Banks would have to post collateral, possibly on longs and shorts, but again, who cares? The IG9 tranche might be the worst case of regulatory misconduct ever. It has $800 billion of tranches outstanding. $150 billion of net outstanding, dwarfing most companies, yet, you cannot get a breakdown of how risky the tranches are, and finding a price if you aren’t in the market is somewhere between difficult and really annoying.
The scale and lack of transparency have to end. The beauty is that it wouldn’t take long to get indices on an exchange if anyone had the will.
Editor's Note: For more from Peter Tchir, check out TF Market Advisors.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.